For global biotech company Novozymes, failing to incorporate the Sustainable Development Goals into the way they work is not an option.
The company is embedding an SDG assessment framework in its innovation pipeline and using it to help determine what products or models it will take to market, said Claus Stig Pedersen, Novozyme’s head of corporate sustainability affairs.
Devex checks in on this approach a year after its inception to find out how it’s working and what it means for the company.
To learn more about how Novozymes is looking at the SDGs, watch the video above.
Watch more international development news online, and subscribe to The Development Newswire to receive the latest from the world’s leading donors and decision-makers — emailed to you FREE every business day.
About the author
Adva Saldinger@AdvaSal
Adva Saldinger is a Senior Reporter at Devex where she covers development finance, as well as U.S. foreign aid policy. Adva explores the role the private sector and private capital play in development and authors the weekly Devex Invested newsletter bringing the latest news on the role of business and finance in addressing global challenges. A journalist with more than 10 years of experience, she has worked at several newspapers in the U.S. and lived in both Ghana and South Africa.
